Increase in popularity of personalized medicines, growth in R&D expenditure, and technological advancements related to proteomics components fuel the global proteomics market. Based on component, the reagents segment held the major share in 2019. By region, on the other hand, the market across North America garnered the major share in the same year.
Portland, OR, March 02, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Proteomics Market was pegged at $21.12 billion in 2019, and is anticipated to reach $49.97 billion by 2027, registering a CAGR of 12.2% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and varying market trends.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/1677
Increase in popularity of personalized medicines, growth in R&D expenditure, and technological advancements related to proteomics components fuel the global proteomics market. On the other hand, lack of skilled professionals and high costs related to proteomics components impede the growth to some extent. Nevertheless, biomarker identification and advancements in mass spectrometry-based proteomics are projected to create an array of opportunities in the coming years.
Proteomic technologies have helped in cognizing the profile of viral proteins that disturb respiratory pathways. Methods such as MS-based detection and RT-PCR are extensively being used to detect SARS-CoV-2 in individuals.
At the same time, proteomics have also aided in revealing novel biomarkers and interpreting point-of-care procedures.
The global proteomics market is analyzed across component, application, and region. Based on component, the reagents segment contributed to more than three-fourths of the total market share in 2019 and would maintain its dominance by 2027. The instruments segment, on the other hand, is projected to register the fastest CAGR of 14.1% from 2020 to 2027.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/1677
Based on application, the drug discovery segment accounted for around three-fifths of the total market revenue in 2019, and would lead the trail by the end of 2027. Simultaneously, the disease diagnosis segment is anticipated to exhibit the fastest CAGR of 12.6% throughout the forecast period.
Based on region, the market across North America held the major share in 2019, garnering nearly two-fifths of the global proteomics market. At the same time, the Asia-Pacific region would manifest the fastest CAGR of 15.6 % from 2020 to 2027. The other two provinces studied in the report include Europe and LAMEA.
The key market players analyzed in the global proteomics market report include Danaher Corporation, General Electric (GE), LI-COR, Inc., Waters Corporation, Agilent Technologies Inc., PerkinElmer, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and Bruker Corporation. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to prove their flair in the industry.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 email@example.com Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research